2016


Aargau


@InterAxBiotech Homepage

Company profile

InterAx Biotech

Drugs work by binding to receptors and thereby triggering a specific reaction by the affected cell. InterAx has developed technology that can more accurately determine the reaction of receptors to which 40% of all drugs bind. This makes it possible to find active ingredients that are more effective and have fewer side-effects.


Source: startup.ch

Highlights

More news about InterAx Biotech

15.01.2019 16:40

InterAx Biotech closed a financing round of CHF 3 million

Financing
Please login or
register to use the
bookmark feature
09.05.2018 16:20

Ten startup founders are set for China

Award
Please login or
register to use the
bookmark feature
19.04.2018 11:52

Two Swiss start-ups pave a new way to cancer drugs

Expansion
Please login or
register to use the
bookmark feature
24.10.2016 13:59

Die Finalisten des Swiss Technology Award stehen fest

Award
Please login or
register to use the
bookmark feature
21.10.2016 14:24

Unternehmenswettbewerb «SWISS UPSTART»: Die Preisträger

Award
Please login or
register to use the
bookmark feature
06.04.2016 16:45

Venturelab presents the 20 Venture leaders of 2016

AwardSupport
Please login or
register to use the
bookmark feature

By continuing to use this website you agree with our TERMS AND CONDITIONS